Cleo Diagnostics (ASX:COV) Dividend Yield % : 0.00% (As of May. 24, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Dividend Yield %?

As of today (2024-05-24), the Trailing Annual Dividend Yield of Cleo Diagnostics is 0.00%.

The historical rank and industry rank for Cleo Diagnostics's Dividend Yield % or its related term are showing as below:

ASX:COV's Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.855
* Ranked among companies with meaningful Dividend Yield % only.

Cleo Diagnostics's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-05-24), the Forward Dividend Yield % of Cleo Diagnostics is 0.00%.

Cleo Diagnostics's Dividends per Share for the six months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Cleo Diagnostics Dividend Yield % Historical Data

The historical data trend for Cleo Diagnostics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Dividend Yield % Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Dividend Yield %

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Dividend Yield %	-	-	-

Competitive Comparison of Cleo Diagnostics's Dividend Yield %

For the Medical Devices subindustry, Cleo Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Dividend Yield % falls into.

Cleo Diagnostics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Cleo Diagnostics (ASX:COV) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Cleo Diagnostics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines